| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Operating activities | ||||||
Net loss | ||||||
-39,612 | -27,897 | -25,980 | -12,086 | -5,889 | ||
Adjustments to reconcile net loss to net cash used by operating activities: | ||||||
Depreciation and amortization | ||||||
1,607 | 1,081 | 551 | 345 | 147 | ||
Loss on disposal of land, buildings and equipment | ||||||
- | -23 | - | - | - | ||
Stock-based compensation | ||||||
9,175 | 4,385 | 12,092 | 948 | 692 | ||
Unrealized foreign exchange loss | ||||||
- | 12 | 34 | - | - | ||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
1,122 | - | -110 | -107 | -25 | ||
Due to/from related parties | ||||||
-882 | 676 | -448 | 1,702 | -1,265 | ||
Inventory | ||||||
2,594 | - | - | - | - | ||
Prepaid expenses and other current assets | ||||||
-493 | 726 | 537 | 387 | -59 | ||
Accounts payable | ||||||
259 | -118 | 665 | 53 | -28 | ||
Accrued expenses | ||||||
537 | 985 | 86 | 137 | 40 | ||
Accrued compensation | ||||||
876 | 360 | 613 | 88 | 93 | ||
Other current liabilities | ||||||
-670 | 940 | 97 | -144 | -565 | ||
Other non-current assets | ||||||
18 | -51 | - | - | - | ||
Net cash used by operating activities | ||||||
-31,951 | -20,252 | -12,785 | -9,237 | -6,691 | ||
Purchases of land, buildings, and equipment | ||||||
2,969 | 1,847 | 779 | 10,424 | 665 | ||
Other | ||||||
- | 50 | - | - | - | ||
Net cash used by investing activities | ||||||
-2,969 | -1,797 | -779 | -10,424 | -665 | ||
Financing activities | ||||||
Costs incurred related to the issuance of stock | ||||||
- | 665 | 3,312 | - | - | ||
Proceeds from common stock issuance | ||||||
- | 57,706 | 61,292 | - | - | ||
Repayments of financing lease obligations | ||||||
275 | - | - | - | - | ||
Capital contribution from Parent | ||||||
- | - | - | - | 30,000 | ||
Advances from Cellectis | ||||||
- | - | 3,000 | - | 2,050 | ||
Repayment of advances from Cellectis | ||||||
- | - | 3,000 | - | 200 | ||
Dividend to Parent | ||||||
- | - | - | - | 110 | ||
Proceeds from the exercise of stock options | ||||||
344 | 2,622 | 265 | - | - | ||
Costs incurred related to shares withheld for net settlement | ||||||
813 | 230 | - | - | - | ||
Proceeds from sale and leaseback of land, buildings and equipment | ||||||
414 | 1,240 | 6,957 | - | - | ||
Net cash (used) provided by financing activities | ||||||
-330 | 60,673 | 65,202 | - | 31,740 | ||
Net decrease in cash, cash equivalents and restricted cash | ||||||
-35,250 | 38,624 | 51,638 | -19,661 | 24,384 | ||
Supplemental cash flow information | ||||||
Interest paid | ||||||
- | - | - | - | 261 | ||